加载中
NYSEHealthcareMedical - Devices
最新数据
US$71.49
+US$2.60 · +3.77%
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
前收盘价
US$71.49
+US$2.60 · +3.77%
盘后
US$71.49
US$0.00 · 0.00%
10月12日 17:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日内区间
当前US$71.49
52周区间
当前US$71.49
盘中时间采用ET。市场数据可能有所延迟。
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
日内区间
当前US$71.49
52周区间
当前US$71.49
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 9.12亿 USD | 8.03亿 USD | 6.25亿 USD | 4.08亿 USD | 2.33亿 USD |
| 销货成本 | 1.33亿 USD | 1.23亿 USD | 9657.6万 USD | 6611.5万 USD | 3327.9万 USD |
| 毛利 | 7.79亿 USD | 6.8亿 USD | 5.28亿 USD | 3.42亿 USD | 2亿 USD |
| 研究与开发 | 1.03亿 USD | 1.14亿 USD | 1.17亿 USD | 6864.5万 USD | 3735万 USD |
| 销售、一般及管理费用 | 6.25亿 USD | 5.3亿 USD | 4.52亿 USD | 3.21亿 USD | 2.03亿 USD |
| 营业费用 | 7.28亿 USD | 6.44亿 USD | 5.68亿 USD | 3.89亿 USD | 2.4亿 USD |
| 利息收入 | 1753.6万 USD | 2324.7万 USD | 2056万 USD | 505万 USD | 12.5万 USD |
| 利息支出 | 13.7万 USD | 2.2万 USD | — | 167.7万 USD | 212.8万 USD |
| 折旧和摊销 | 1395.7万 USD | 655万 USD | 284.6万 USD | 185.8万 USD | 121.8万 USD |
| 营业利润 | 5095.4万 USD | 3608.3万 USD | −4027.1万 USD | −4759.2万 USD | −3985万 USD |
| 净利润 | 1.45亿 USD | 5350.9万 USD | −2115.3万 USD | −4488.1万 USD | −4204.2万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$62.55
下跌空间 12.51%价格历史记录不可用
最高：US$85.00平均的：US$62.55最低：US$39.00| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2008年1月9日 | US$9.00Irregular | — | — |
除息 2008年1月9日
US$9.00
Irregular
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
